Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of the engrailed homeodomain protein as anxiolytic

Use of the engrailed homeodomain protein as anxiolytic

US Patent 8575105 · Granted Nov 5, 2013

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Ligand controling interaction between gags with their effector molecules and use2022
Methods of delivering a polypeptide molecule to Otx2 target cells using an Otx2 2020
Methods of reducing excitotoxicity-induced retinal ganglionic neuron degeneratio2020
Use of engrailed proteins for increasing dopamine synthesis by dopaminergic neur2019
Use of a reverse-transcriptase inhibitor in the prevention and treatment of dege2018
Use of engrailed proteins for increasing dopamine synthesis by dopaminergic neur2018
Inhibition of the synthesis of beta-app or the activity of the A-β peptide in th2018
Carrier vectors through an epithelium with tight junctions2012
Applications of peptides derived from the cytoplasmic domain of amyloid precurso2006
Uses of peptides derived from the cytoplasmic domain of the amyloid protein prec2005
Method for identification of target genes of transcription factors2003
Peptides which can be used as vectors for the intracellular addressing of active2000